Literature DB >> 22087170

IL28B SNP genotyping among Iranian HCV-infected patients: A preliminary report.

Nastaran Mahboobi1, Bita Behnava, Seyed Moayed Alavian.   

Abstract

Entities:  

Keywords:  Genotype; Hepatitis C virus; IL28B; Iran

Year:  2011        PMID： 22087170      PMCID： PMC3212776     

Source DB:  PubMed          Journal:  Hepat Mon        ISSN： 1735-143X            Impact factor:   0.660


× No keyword cloud information.
  8 in total

1.  Seroprevalence of hepatitis C virus: the first population-based study from Iran.

Authors:  Shahin Merat; Houri Rezvan; Mehdi Nouraie; Elham Jafari; Hassan Abolghasemi; Amir Reza Radmard; Hanieh Zaer-rezaii; Sedigheh Amini-Kafiabad; Mahtab Maghsudlu; Akram Pourshams; Reza Malekzadeh; Saeed Esmaili
Journal:  Int J Infect Dis       Date:  2010-04-02       Impact factor: 3.623

Review 2.  Hepatitis C pharmacogenetics: state of the art in 2010.

Authors:  Nezam H Afdhal; John G McHutchison; Stefan Zeuzem; Alessandra Mangia; Jean-Michel Pawlotsky; Jeffrey S Murray; Kevin V Shianna; Yasuhito Tanaka; David L Thomas; David R Booth; David B Goldstein
Journal:  Hepatology       Date:  2011-01       Impact factor: 17.425

Review 3.  IL28B and the control of hepatitis C virus infection.

Authors:  Ashwin Balagopal; David L Thomas; Chloe L Thio
Journal:  Gastroenterology       Date:  2010-10-13       Impact factor: 22.682

Review 4.  IL28B in hepatitis C virus infection: translating pharmacogenomics into clinical practice.

Authors:  Golo Ahlenstiel; David R Booth; Jacob George
Journal:  J Gastroenterol       Date:  2010-07-16       Impact factor: 7.527

5.  Genetic variation in IL28B predicts hepatitis C treatment-induced viral clearance.

Authors:  Dongliang Ge; Jacques Fellay; Alexander J Thompson; Jason S Simon; Kevin V Shianna; Thomas J Urban; Erin L Heinzen; Ping Qiu; Arthur H Bertelsen; Andrew J Muir; Mark Sulkowski; John G McHutchison; David B Goldstein
Journal:  Nature       Date:  2009-08-16       Impact factor: 49.962

6.  IL28B is associated with response to chronic hepatitis C interferon-alpha and ribavirin therapy.

Authors:  Vijayaprakash Suppiah; Max Moldovan; Golo Ahlenstiel; Thomas Berg; Martin Weltman; Maria Lorena Abate; Margaret Bassendine; Ulrich Spengler; Gregory J Dore; Elizabeth Powell; Stephen Riordan; David Sheridan; Antonina Smedile; Vincenzo Fragomeli; Tobias Müller; Melanie Bahlo; Graeme J Stewart; David R Booth; Jacob George
Journal:  Nat Genet       Date:  2009-09-13       Impact factor: 38.330

7.  Single nucleotide polymorphisms of the IL28B and sustained virologic response of patients with chronic hepatitis C to PEG-interferon/ribavirin therapy: A meta-analysis: Meta-analysis of IL28B.

Authors:  Shiying Li; Peng Hu; Qin-Qin Zhang; Ying-Hong Liu; Huai-Dong Hu; Da-Zhi Zhang; Hong Ren
Journal:  Hepat Mon       Date:  2011-03       Impact factor: 0.660

8.  Genetic variation in IL28B and spontaneous clearance of hepatitis C virus.

Authors:  David L Thomas; Chloe L Thio; Maureen P Martin; Ying Qi; Dongliang Ge; Colm O'Huigin; Judith Kidd; Kenneth Kidd; Salim I Khakoo; Graeme Alexander; James J Goedert; Gregory D Kirk; Sharyne M Donfield; Hugo R Rosen; Leslie H Tobler; Michael P Busch; John G McHutchison; David B Goldstein; Mary Carrington
Journal:  Nature       Date:  2009-10-08       Impact factor: 49.962
  8 in total
  6 in total

1.  Polymorphism of IL-28B Gene (rs12979860) in HCV Genotype 1Patients Treated by Pegylated Interferon and Ribavirin.

Authors:  Fahimeh Safarnezhad Tameshkel; Mohammad Hadi Karbalaie Niya; Msuodreza Sohrabi; Mahshid Panahi; Farhad Zamani; Farid Imanzade; Nasser Rakhshani
Journal:  Iran J Pathol       Date:  2016

2.  Mysterious Linkages Between Hepatitis C Virus Genotypes, Interleukin-28B Genotypes and Viral Clearance- A Meta-Analysis.

Authors:  Seyed Hossein Aalaei-Andabili; Bita Behnava; Shima Salimi; Heidar Sharafi; Seyed Moayed Alavian
Journal:  Hepat Mon       Date:  2014-03-02       Impact factor: 0.660

3.  Prevalence of interleukin-28B single nucleotide polymorphism genotypes in patients with hepatitis C infection in Isfahan, Iran.

Authors:  Mohammad Minakari; Marjan Golshani; Majid Yaran; Behrooz Ataei
Journal:  Adv Biomed Res       Date:  2016-05-30

4.  Lack of association between interleukin 28B gene polymorphisms (rs8099917G/T, rs12979860 C/T) and susceptibility to chronic hepatitis C virus infection, Tehran, Iran.

Authors:  Maryam Karkhane; Seyed Reza Mohebbi; Pedram Azimzadeh; Mahsa Saeedi Niasar; Mohamad Reza Sarbazi; Afsaneh Sharifian; Afshin Mohammad Alizadeh
Journal:  Gastroenterol Hepatol Bed Bench       Date:  2016-12

5.  Role of IL28-B Polymorphism (rs12979860) on Sustained Virological Response to Pegylated Interferon/Ribavirin in Iranian Patients With Chronic Hepatitis C.

Authors:  Mahtab Daneshvar; Mehri Nikbin; Solmaz Talebi; Foozieh Javadi; Mohammad Reza Aghasadeghi; Sanaz Mahmazi; Seyed Mehdi Sadat
Journal:  Iran Red Crescent Med J       Date:  2016-07-17       Impact factor: 0.611

6.  High Rate of Virological Response to Peginterferon α-2a-Ribavirin Among Non-Cirrhotic Iranian Hemophilia Patients With Chronic Hepatitis C.

Authors:  Mostafa Alavi Moghaddam; Mohammad Reza Zali; Seyed Hossein Aalaei Andabili; Faramarz Derakhshan; Seyed Mohammad Miri; Seyed Moayed Alavian
Journal:  Iran Red Crescent Med J       Date:  2012-08-30       Impact factor: 0.611
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.